open access

Vol 6, No 4 (2021)
Original article
Published online: 2021-11-16
Get Citation

Frequency and relationship of ABO blood groups in patients with nephrotic syndrome

İdris Oruç1, Hıdır Sarı2, Songül Araç3, Eren Eynel1, Zafer Pekkolay4, Ali Kemal Kadiroğlu1, Zülfikar Yılmaz1, Fatma Yılmaz Aydın5, Emre Aydın1, Yaşar Yıldırım1
·
Medical Research Journal 2021;6(4):301-304.
Affiliations
  1. Department of Nephrology — Internal Medicine, Faculty of Medicine, Dicle University, Diyarbakır, Turkey
  2. Faculty of Medicine, Department of Public Health, Dicle University, Diyarbakır, Turkey
  3. Department of Internal Medicine, Unıversity of Health Sciences, Diyarbakır Gazi Yaşargil Training and Research Hospital, Turkey
  4. Department of Endocrinology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey
  5. Department of Internal Medicine, Faculty of Medicine, Dicle University, Diyarbakır, Turkey

open access

Vol 6, No 4 (2021)
ORIGINAL ARTICLES
Published online: 2021-11-16

Abstract

Aim of the study: To investigate the frequency of ABO blood groups and the relationship between nephrotic syndrome (NS) and blood groups in patients with NS.
Material and methods: 199 patients with a diagnosis of NS and 200 healthy individuals, who applied to Dicle University Faculty of Medicine, Department of Nephrology between 2016 and 2020, and whose blood group information was in the records, were included in the study as the control group. This study was carried out retrospectively using data from the file registration system in our hospital.
Results: In the study, there were 199 patients: 52.8% (n = 105) male and 47.2% (n = 94) female and 200 healthy individuals: 47.5% male (n = 95) 52.5% female (n = 105). The mean age of the patients was 35.79 ± 12.21 (min-max: 17–71), and the mean proteinuria was 7.08 ± 4.33 (min-max: 3.50–25.50). There was no difference between sick and healthy individuals in terms of age or sex (p > 0.05). It was determined that 43.2% of the patients had blood group A, 26.1% blood group O, 25.1% blood group B, and 5.5% blood group AB. There was no significant difference between blood groups of patients with NS and individuals in the healthy group (p > 0.05). Membranous glomerulonephritis (MGN) (27.9%) was most common in blood group A; FSGS was detected most frequently in blood groups B (46.0%), O (28.8%), and AB (36.4%). The most common cause of NS was focal segmental glomerulosclerosis (FSGS) in 31.2% (n = 62), and MGN was the second common cause in 19.1% (n = 38), blood group B (37.1%) in FSGS, blood group O (46.7%) in systemic lupus erythematosus, MGN (63.2%), IgA nephropathy (50%), and MPGN (52.2%) was found most frequently in blood group A.
Conclusions: We did not find a significant relationship between the blood group and NS in our study.

Abstract

Aim of the study: To investigate the frequency of ABO blood groups and the relationship between nephrotic syndrome (NS) and blood groups in patients with NS.
Material and methods: 199 patients with a diagnosis of NS and 200 healthy individuals, who applied to Dicle University Faculty of Medicine, Department of Nephrology between 2016 and 2020, and whose blood group information was in the records, were included in the study as the control group. This study was carried out retrospectively using data from the file registration system in our hospital.
Results: In the study, there were 199 patients: 52.8% (n = 105) male and 47.2% (n = 94) female and 200 healthy individuals: 47.5% male (n = 95) 52.5% female (n = 105). The mean age of the patients was 35.79 ± 12.21 (min-max: 17–71), and the mean proteinuria was 7.08 ± 4.33 (min-max: 3.50–25.50). There was no difference between sick and healthy individuals in terms of age or sex (p > 0.05). It was determined that 43.2% of the patients had blood group A, 26.1% blood group O, 25.1% blood group B, and 5.5% blood group AB. There was no significant difference between blood groups of patients with NS and individuals in the healthy group (p > 0.05). Membranous glomerulonephritis (MGN) (27.9%) was most common in blood group A; FSGS was detected most frequently in blood groups B (46.0%), O (28.8%), and AB (36.4%). The most common cause of NS was focal segmental glomerulosclerosis (FSGS) in 31.2% (n = 62), and MGN was the second common cause in 19.1% (n = 38), blood group B (37.1%) in FSGS, blood group O (46.7%) in systemic lupus erythematosus, MGN (63.2%), IgA nephropathy (50%), and MPGN (52.2%) was found most frequently in blood group A.
Conclusions: We did not find a significant relationship between the blood group and NS in our study.

Get Citation

Keywords

nephrotic syndrome, ABO blood groups, proteinuria

About this article
Title

Frequency and relationship of ABO blood groups in patients with nephrotic syndrome

Journal

Medical Research Journal

Issue

Vol 6, No 4 (2021)

Article type

Original article

Pages

301-304

Published online

2021-11-16

Page views

6028

Article views/downloads

673

DOI

10.5603/MRJ.a2021.0050

Bibliographic record

Medical Research Journal 2021;6(4):301-304.

Keywords

nephrotic syndrome
ABO blood groups
proteinuria

Authors

İdris Oruç
Hıdır Sarı
Songül Araç
Eren Eynel
Zafer Pekkolay
Ali Kemal Kadiroğlu
Zülfikar Yılmaz
Fatma Yılmaz Aydın
Emre Aydın
Yaşar Yıldırım

References (26)
  1. Braden G, Mulhern J, O'Shea M, et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000; 35(5): 878–883.
  2. Eddy A, Symons J. Nephrotic syndrome in childhood. Lancet. 2003; 362(9384): 629–639.
  3. Rivera F, López-Gómez JM, Pérez-García R, et al. Spanish Registry of Glomerulonephritis. Clinicopathologic correlations of renal pathology in Spain. Kidney Int. 2004; 66(3): 898–904.
  4. Temel Medikal Genetik. Ankara Üniversitesi Tip Fakültesi Yayinlari, 430. Ankara, 1982.
  5. Arac E, Solmaz I, Akkoc H, et al. Association between the Rh blood group and the COVID-19 susceptibility. Int J Hematol Oncol. 2020; 30(2): 81–86.
  6. Song C, Leng J, Wang L, et al. ABO blood types and postpartum depression among Chinese women: a prospective cohort study in Tianjin, China. Women Health. 2018; 58(6): 685–698.
  7. Celić D, Lipozenčić J, Kolarić B, et al. Association between blood group and nonmelanoma skin cancers (basal cell carcinoma and squamous cell carcinoma). Int J Environ Res Public Health. 2019; 16(13): 2267.
  8. Li N, Xu M, Li CF, et al. Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center. Chin J Cancer. 2015; 34(10): 475–482.
  9. Teshome Y, Mekonen W, Birhanu Y, et al. The association between ABO blood group distribution and peptic ulcer disease: a cross-sectional study from Ethiopia. J Blood Med. 2019; 10: 193–197.
  10. Ben Q, Liu J, Wang W, et al. Association between ABO blood types and sporadic pancreatic neuroendocrine tumors in the Chinese Han population. Oncotarget. 2017; 8(33): 54799–54808.
  11. Çildağ S, Kara Y, Şentürk T. ABO blood groups and rheumatic diseases. Eur J Rheumatol. 2017; 4(4): 250–253.
  12. Cheng Y, Cheng G, Chui CH, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA. 2005; 293(12): 1450–1451.
  13. Hamed IA, Mandal AK, Parker D, et al. ABO blood groups and renal disease. Ann Clin Lab Sci. 1979; 9(6): 524–526.
  14. Alanan U, Abbas A, Sulaiman I. Relationship between ABO blood group and end-stage renal disease in Latakia, Syria. Saudi J Kidney Dis Transpl. 2017; 28(2): 445.
  15. Voigtmann B, Burchardt U. ABO blood groups in patients with nephropathies. Z Gesamte Inn Med. 1991; 46(5): 156–159.
  16. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 341(23): 1725–1730.
  17. Abbas AO, Hassan F, Abdulla MH, et al. The relationship between ABO blood group antigens and renal function test among chronic kidney disease patients in Khartoum state. Saudi J Biomed Res. 2019; 4(1): 33–36.
  18. Alhawary SY, Al-Abdallat ME, Alamro SAA, et al. Frequency of blood groups amonga sample of patıentswıth renal faılure at royal medıcal servıces. Eur Sci J. 2015; 11(33).
  19. Wang M, Lv J, Chen P, et al. Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathy. Nephrol Dial Transplant. 2021; 36(2): 288–294.
  20. Paré G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008; 4(7): e1000118.
  21. Melzer D, Perry JRB, Hernandez D, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 2008; 4(5): e1000072.
  22. Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010; 140(2): 197–208.
  23. Yamamoto F, Cid E, Yamamoto M, et al. ABO research in the modern era of genomics. Transfus Med Rev. 2012; 26(2): 103–118.
  24. Paré G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008; 4(7): e1000118.
  25. Franchini M, Capra F, Targher G, et al. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J. 2007; 5: 14.
  26. Yang M, Xie J, Ouyang Y, et al. ABO blood type is associated with renal outcomes in patients with IgA nephropathy. Oncotarget. 2017; 8(43): 73603–73612.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl